Medof ME - Search Results

1

Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells.

Walter EI, Ratnoff WD, Long KE, Kazura JW, Medof ME. Walter EI, et al. Among authors: medof me. J Biol Chem. 1992 Jan 15;267(2):1245-52. J Biol Chem. 1992. PMID: 1370460 Free article.

2

Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.

Ratnoff WD, Knez JJ, Prince GM, Okada H, Lachmann PJ, Medof ME. Ratnoff WD, et al. Among authors: medof me. Clin Exp Immunol. 1992 Mar;87(3):415-21. doi: 10.1111/j.1365-2249.1992.tb03012.x. Clin Exp Immunol. 1992. PMID: 1371955 Free PMC article.

3

Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones.

Hirose S, Mohney RP, Mutka SC, Ravi L, Singleton DR, Perry G, Tartakoff AM, Medof ME. Hirose S, et al. Among authors: medof me. J Biol Chem. 1992 Mar 15;267(8):5272-8. J Biol Chem. 1992. PMID: 1371997 Free article.

4

Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.

Hirose S, Ravi L, Prince GM, Rosenfeld MG, Silber R, Andresen SW, Hazra SV, Medof ME. Hirose S, et al. Among authors: medof me. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6025-9. doi: 10.1073/pnas.89.13.6025. Proc Natl Acad Sci U S A. 1992. PMID: 1378620 Free PMC article.

5

Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine.

Hirose S, Prince GM, Sevlever D, Ravi L, Rosenberry TL, Ueda E, Medof ME. Hirose S, et al. Among authors: medof me. J Biol Chem. 1992 Aug 25;267(24):16968-74. J Biol Chem. 1992. PMID: 1380957 Free article.

6

Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants.

Armstrong C, Schubert J, Ueda E, Knez JJ, Gelperin D, Hirose S, Silber R, Hollan S, Schmidt RE, Medof ME. Armstrong C, et al. Among authors: medof me. J Biol Chem. 1992 Dec 15;267(35):25347-51. J Biol Chem. 1992. PMID: 1460030 Free article.

7

Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.

Carothers DJ, Hazra SV, Andreson SW, Medof ME. Carothers DJ, et al. Among authors: medof me. J Clin Invest. 1990 Jan;85(1):47-54. doi: 10.1172/JCI114432. J Clin Invest. 1990. PMID: 1688570 Free PMC article.

8

Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.

Walter EI, Roberts WL, Rosenberry TL, Ratnoff WD, Medof ME. Walter EI, et al. Among authors: medof me. J Immunol. 1990 Feb 1;144(3):1030-6. J Immunol. 1990. PMID: 1688588

9

Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.

Lass JH, Walter EI, Burris TE, Grossniklaus HE, Roat MI, Skelnik DL, Needham L, Singer M, Medof ME. Lass JH, et al. Among authors: medof me. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1136-48. Invest Ophthalmol Vis Sci. 1990. PMID: 1693916

10

The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.

Mold C, Walter EI, Medof ME. Mold C, et al. Among authors: medof me. J Immunol. 1990 Dec 1;145(11):3836-41. J Immunol. 1990. PMID: 1700997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters